雜志介紹

Pathology & Oncology Research雜志介紹

《Pathology & Oncology Research》是一本以English為主的未開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱病理學(xué)和腫瘤學(xué)研究，本刊主要出版、報(bào)道醫(yī)學(xué)-ONCOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為2.3，最新CiteScore 指數(shù)為6.3。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps

  Author: Zuo, Yanhua; Leng, Guangyi; Leng, Ping

• Case report: Circulating tumor DNA technology displays temporal and spatial heterogeneity in Waldenstrom macroglobulinemia during treatment with BTK inhibitors

  Author: Zhu, Jingjing; Zhu, Xinyu; Xie, Fengyang; Ding, Yi; Lu, Huina; Dong, Yan; Li, Ping; Fu, Jianfei; Liang, Aibin; Zeng, Yu; Xiu, Bing

• Development and validation of a prognostic nomogram for rectal cancer patients who underwent surgical resection

  Author: Zhao, Bochao; Wang, Jingchao; Ma, Zhicheng; Ye, Haikun; Yang, Tao; Meng, Kewei

• Expression significance of Emi1, UBCH10 and CyclinB1 in esophageal squamous cell carcinoma

  Author: Li, Hui; Yang, Chenbo; Chen, Kuisheng; Sun, Miaomiao

英文介紹

Pathology & Oncology Research雜志英文介紹

Pathology & Oncology Research (POR) is an interdisciplinary Journal at the interface of pathology and oncology including the preclinical and translational research, diagnostics and therapy. Furthermore, POR is an international forum for the rapid communication of reviews, original research, critical and topical reports with excellence and novelty. Published quarterly, POR is dedicated to keeping scientists informed of developments on the selected biomedical fields bridging the gap between basic research and clinical medicine. It is a special aim for POR to promote pathological and oncological publishing activity of colleagues in the Central and East European region. The journal will be of interest to pathologists, and a broad range of experimental and clinical oncologists, and related experts. POR is supported by an acknowledged international advisory board and the Arányi Fundation for modern pathology.